KS

Komal Singh Sisodiya

Active Director Director DIN 11063314
DIN 11063314 First appointment Apr 2025 Primary industry FMCG
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Komal Singh Sisodiya

Data last updated:

Komal Singh Sisodiya is a Director at Dermakrom Healthcare Private Limited (since 2025). The company operates in FMCG.

DIN 11063314
Primary Designation Director
Industry FMCG
First Appointment 22 Apr 2025
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dermakrom Healthcare Private Limited U24290GJ2021PTC120617
Director22 Apr 20252021Active

Board colleagues of Komal Singh Sisodiya

Directorship timeline

Open interactive timeline →
Dermakrom Healthcare Private Limited
Premium access

Shareholding and investment profile for Komal Singh Sisodiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Komal Singh Sisodiya

Komal Singh Sisodiya currently holds 1 directorship: Dermakrom Healthcare Private Limited (Director, since 22 Apr 2025).

Komal Singh Sisodiya was first appointed on 22 Apr 2025 as Director at Dermakrom Healthcare Private Limited.

The current boards of Komal Singh Sisodiya's companies include Jigar Ashokbhai Dave (Dermakrom Healthcare Private Limited), Mukesh Govindbhai Dorara (Dermakrom Healthcare Private Limited), Raman Singh Tomar (Dermakrom Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available